medline.ch Dermatologie Psoriasis

	Biological activity study of a pine pollen extract rich in dihydroquercetin for the treatment of psoriasis. Phytomedicine Xu Q, Chen Y, Dong Y, Li G, Yan M. PMID: 41447846 [PubMed - as supplied by publisher]
	Prevalence of tobacco smoking and its association with disease severity and psoriatic arthritis among patients with nail psoriasis in China: a cross-sectional study. Front Med (Lausanne) Yang X, Lu L, Zhou H, Xu X, Lin B. PMID: 41446844 [PubMed]
	Factors influencing quality of life in patients with psoriasis: A large cross-sectional study. Chin Med J (Engl) Wang J, Lin Z, Wu X, Hong X, Tian G, Li H, Luo D, Zhang G, Huang C, Zhang K, Chen C, Cui M, Tian W, Zhong W, Yu B, Zou Y, Liang B, Shen C, Gao J. PMID: 41443943 [PubMed - as supplied by publisher]
	Clinical differentiation between acute generalized exanthematous pustulosis and generalized pustular psoriasis: A multi-center study. Chin Med J (Engl) Guo S, Wang X, Cheng W, Qi Z, Sun Y, Ma L, Wang F, Jiang G. PMID: 41443937 [PubMed - as supplied by publisher]
	Equitable Access to Biologic Therapies in a Psoriasis Safety-Net Clinic: A retrospective cohort study. Clin Dermatol Mufarrej S, Rongioletti F, Romanelli P. PMID: 41443396 [PubMed - as supplied by publisher]
	Psoriatic Arthritis Features and Risk of Cardiovascular Events: A Nationwide Cohort Study. Cureus Sanchez Baez R, Kavanaugh A, Guma M, Kremer JM, Reed G. PMID: 41439091 [PubMed]
	Serum neutrophil gelatinase-associated lipocalin as a potential signature for acute generalized exanthematous pustulosis and generalized pustular psoriasis: A case-control study. JAAD Int Shou Y, Zhang M. PMID: 41439016 [PubMed]
	Antibodies Targeting Gasdermin E as a Potential Therapeutic Option for Psoriasis - A Pilot Study on a Mouse Model. Psoriasis (Auckl) Nowowiejska-Purpurowicz J, Hermanowicz JM, Pawlak D, Flisiak I, Lipinski T. PMID: 41438421 [PubMed]
	Assessing internal construct validity of DAPSA and DAPSA28 in psoriatic arthritis: a European observational study using confirmatory factor analysis and additional psychometric testing. RMD Open Jørgensen JB, Christensen KB, Michelsen B, Loft AG, Horskjær Rasmussen S, Heberg J, Hetland ML, Zavada J, Pavelka K, Iannone F, Conti F, Borges J, Codreanu C, Mogosan C, Glintborg B, Ciurea A, Nissen MJ, Nordström D, Kuusalo L, Laas K, Vorobjov S, Gudbjornsson B, Love TJ, Østergaard M, Ørnbjerg LM. PMID: 41436138 [PubMed - indexed for MEDLINE]
	Evaluating the Body Roundness Index as a Novel Digital Biomarker for Psoriasis Risk Prediction: Cross-Sectional Study. JMIR Med Inform Wen P, Wang X, Zhuo X, Xue S. PMID: 41432618 [PubMed - indexed for MEDLINE]
	Interface-Engineered Nanocarriers for Translational and Patient-Centric Topical Therapy in Psoriasis. Drug Dev Res Singh V, Rehman U, Alqahtani T, Shmrany HA, Gupta G, Goh KW, Kesharwani P. PMID: 41431180 [PubMed - indexed for MEDLINE]
	Immunogenicity of Biosimilar Therapies for Psoriasis in Head-to-Head Trials. J Am Acad Dermatol Smith LR, Feldman SR. PMID: 41429207 [PubMed - as supplied by publisher]
	Neuroimmune Crosstalk in Psoriasis: Mechanisms and Therapeutic Implications. Inflammation Gao H, Fang Y, Zhang Y, Xie T, Chen Z, Wang G. PMID: 41428266 [PubMed - in process]
	Late-onset psoriatic arthritis: data from a nationwide cross-sectional study. Ther Adv Musculoskelet Dis Karagianni S, Eleftheraki A, Papagoras C, Gazi S, Mole E, Krikelis M, Voulgari PV, Kaltsonoudis E, Koletsos N, Boumpas D, Katsimpri P, Katsifis-Nezis D, Dimitroulas T, Kougkas N, Sfikakis PP, Tektonidou MG, Vassilakis KD, Bogdanos D, Simopoulou T, Koutsianas C, Mavrea E, Katsifis G, Kottas K, Konsta M, Tziafalia M, Kataxaki E, Kalavri E, Klavdianou K, Karamanakos A, Xynogalas I, Daoussis D, Iliopoulos G, Bournazos I, Georganas C, Patrikos D, Vassilopoulos D, Fragoulis GE. PMID: 41427120 [PubMed]
	Psoriasis and gut microbes: research advances from mechanism to therapy. Front Microbiol Chen J, Sun K, Zhang X, Chen X, Chu Y, Geng L, Bian Z, Su Y, Cong X, Wang G. PMID: 41425939 [PubMed]
	Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis. JCI Insight Strawn D, Krueger JG, Bissonnette R, Eyerich K, Ferris LK, Paller AS, Pinter A, Richards D, Chen EY, Paget K, Horowitz D, Parast R, Rusbuldt JJ, Sendecki J, Bhagat S, Tomsho LP, Chou CH, Polak ME, Keyes BE, Bozenhardt E, Xiong Y, Zhou W, DeKlotz C, Newbold P, Waterworth DM, Miller M, Ota T, Yang YW, Leung MW, Miller LS, Cuff CA, McRae B, Ruane D, Kannan AK. PMID: 41424381 [PubMed - indexed for MEDLINE]
	Certolizumab-associated autoimmune-like hepatitis. BMJ Case Rep Peggie E, Shetty S, Johnston M, May C, Oien K, Kohnen G. PMID: 41423287 [PubMed - indexed for MEDLINE]
	Relation between gut microbiome and inflammatory interleukins in psoriasis patients compared to healthy controls: an observational study. Actas Dermosifiliogr Schneller-Pavelescu L, Mora-Martínez C, Sánchez-Pujol MJ, Sanz Y, Caparrós-Cayuela E, Francés-Guarinos R, Ramos-Rincón JM, Belinchón-Romero I. PMID: 41421479 [PubMed - as supplied by publisher]
	Cancer Progression, Recurrence, and Infection Outcomes in Psoriasis Patients with Active or Recent Malignancy Treated with Biologic Therapy: A Cohort Study Showing Comparable Safety to Conventional Agents. J Am Acad Dermatol Bar D, Brilant L, Lidar M, Barzilai A, Baum S. PMID: 41419137 [PubMed - as supplied by publisher]
	SYHX1901, an oral dual JAK/SYK inhibitor, for moderate-to-severe plaque psoriasis: a randomized phase 2 trial. J Am Acad Dermatol Han L, Zhu L, Yu G, Cheng F, Cao L, Pei Z, Qin X, Mu K, Zhang S, Liang X, Li S, Ding Y, Zhu Q, Shi C, Man X, Kang X, Zhang F, Wu S, Xu J. PMID: 41419128 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 27213

Seite 1 von 1361

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung